These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1808921

  • 1. [Prospects for vaccine development against HIV infection].
    Kurth R, Binninger D, Ennen J, Denner J, Hartung S, Norley S.
    Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
    [No Abstract] [Full Text] [Related]

  • 2. [Development of a vaccine against HIV: is this aim accomplishable?].
    Wagner R, Asbach B.
    MMW Fortschr Med; 2013 Jun 13; 155 Suppl 1():36-9. PubMed ID: 23961653
    [No Abstract] [Full Text] [Related]

  • 3. [Biotechnology vaccines--development of new disease prevention. Research progress of Biocine in Siena--HIV, herpes, Helicobacter].
    Keil TU.
    Fortschr Med; 1994 Apr 20; 112(11):53-4. PubMed ID: 8200601
    [No Abstract] [Full Text] [Related]

  • 4. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
    Sundbäck M, Douagi I, Dayaraj C, Forsell MN, Nordström EK, McInerney GM, Spångberg K, Tjäder L, Bonin E, Sundström M, Liljeström P, Karlsson Hedestam GB.
    Virology; 2005 Oct 25; 341(2):190-202. PubMed ID: 16098555
    [Abstract] [Full Text] [Related]

  • 5. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D, Elizaga M, Duerr A.
    Infect Dis Clin North Am; 2007 Mar 25; 21(1):201-17, x. PubMed ID: 17502236
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outwitting HIV: Minnesota researchers take on a clever virus.
    Bell H.
    Minn Med; 2009 Oct 25; 92(10):22-6. PubMed ID: 19916268
    [No Abstract] [Full Text] [Related]

  • 12. Thailand's Prime-Boost HIV Vaccine Phase III.
    Trinvuthipong C.
    Science; 2004 Feb 13; 303(5660):954-5. PubMed ID: 14963308
    [No Abstract] [Full Text] [Related]

  • 13. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL.
    Nat Rev Immunol; 2006 Dec 13; 6(12):930-9. PubMed ID: 17124514
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
    McFarland EJ, Borkowsky W, Fenton T, Wara D, McNamara J, Samson P, Kang M, Mofenson L, Cunningham C, Duliege AM, Sinangil F, Spector SA, Jimenez E, Bryson Y, Burchett S, Frenkel LM, Yogev R, Gigliotti F, Luzuriaga K, Livingston RA, AIDS Clinical Trials Group 230 Collaborators.
    J Infect Dis; 2001 Nov 15; 184(10):1331-5. PubMed ID: 11679925
    [Abstract] [Full Text] [Related]

  • 17. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL, Hahn BH.
    AIDS; 2000 Nov 15; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.